Fonar Corporation (FONR)

In the past six months, FONAR Corp.'s stock was impacted by an acquisition proposal led by its CEO to take the company private, culminating in a definitive merger agreement at $19.00 per share, expected to close in Q3 2026, leading to Nasdaq delisting. Financial results also influenced the stock, with fluctuating revenues and net income reported for fiscal quarters 2025 and 2026. Additionally, Vanguard (FONR) amended its Schedule 13G/A, reporting 0% ownership on March 26, 2026.

Specific details of demand seasonality for FONAR Corp.'s products and services are not explicitly provided. The company aims to stabilize revenues by expanding its managed services, suggesting that equipment sales might have some cyclicality.

FONAR Corporation is a U.S.-based company in the healthcare sector, focusing on Diagnostics & Research and Health Care Equipment. It designs, manufactures, sells, and services MRI scanners, known for its UPRIGHT® Multi-Position™ MRI technology. FONAR also operates in Physician Management and Diagnostic Services through its subsidiary, Health Management Company of America (HMCA), managing diagnostic imaging centers.

FONAR's operations are mainly in North America, with its headquarters in Melville, New York. Its managed diagnostic imaging centers and MRI systems are primarily located across the U.S. While it has marketed MRI systems internationally, its global influence is primarily technological, with limited operational presence outside the United States.

FONAR's brand reputation is based on its historical significance as "The Inventor of MR Scanning™." Events affecting FONAR's public perception in the past year have been related to its financial performance and the proposed take-private transaction.

FONAR Corp. has a mixed ownership structure, including institutional, insider, and retail investors. Institutional shareholders hold approximately 39.45% of the stock, insiders hold 3.60%, and retail investors hold 56.95%. Raymond V. Damadian, the company's founder, is the largest individual shareholder, owning 2.10% of the company's shares.